Related Experiment Videos
Glycylprolyl beta-naphthylamidase activity in human serum
Summary
Glycylprolyl beta-naphthylamidase enzyme activity in serum varies by sex and is altered in gastric cancer and hepatobiliary diseases. Electrophoresis reveals distinct protein patterns in liver conditions.
Area of Science:
- Biochemistry
- Clinical Chemistry
Background:
- Glycylprolyl beta-naphthylamidase is an enzyme found in human serum.
- Understanding its activity and variations is crucial for diagnostic purposes.
Purpose of the Study:
- To investigate the activity of glycylprolyl beta-naphthylamidase in normal individuals.
- To determine the enzyme's activity in relation to age, sex, and specific diseases.
- To explore the enzyme's electrophoretic behavior in various serum conditions.
Main Methods:
- Serum samples from 40 normal subjects were analyzed for enzyme activity at 37°C.
- Activity levels were compared between age groups (under and over 40) and sexes.
- Enzyme activity was assessed in patients with gastric cancer and hepatobiliary diseases.
- Cellulose acetate electrophoresis was performed on normal and diseased sera.
Main Results:
- Normal serum glycylprolyl beta-naphthylamidase activity was 22.6 +/- 0.9 I.U./L.
- Activity did not significantly differ with age but was higher in males, particularly those under 40.
- Enzyme levels were decreased in gastric cancer patients and elevated in hepatobiliary disease patients.
- Significant correlations were observed between enzyme activity and markers of hepatic disease (AST, ALT, ALP, bilirubin), but not LDH.
- Electrophoresis showed a single beta-globulin peak in normal sera, with additional alpha1 and alpha2-globulin peaks in hepatitis and liver cirrhosis.
Conclusions:
- Serum glycylprolyl beta-naphthylamidase activity is influenced by sex and is a potential biomarker for gastric cancer and hepatobiliary diseases.
- Electrophoretic analysis of this enzyme may aid in diagnosing liver conditions like hepatitis and cirrhosis.